GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $6,000 | -66.7% | 2,976 | -62.7% | 0.00% | – |
Q4 2020 | $18,000 | +20.0% | 7,976 | +65.3% | 0.00% | – |
Q2 2020 | $15,000 | +66.7% | 4,824 | +1.4% | 0.00% | – |
Q1 2020 | $9,000 | +200.0% | 4,759 | +499.4% | 0.00% | – |
Q3 2019 | $3,000 | -95.4% | 794 | -94.9% | 0.00% | -100.0% |
Q2 2019 | $65,000 | +282.4% | 15,562 | +213.4% | 0.00% | – |
Q4 2018 | $17,000 | -94.0% | 4,965 | -89.4% | 0.00% | -100.0% |
Q3 2018 | $282,000 | -59.1% | 46,965 | -56.7% | 0.00% | -66.7% |
Q2 2018 | $690,000 | +2775.0% | 108,491 | +2005.8% | 0.01% | – |
Q1 2018 | $24,000 | -51.0% | 5,152 | -77.7% | 0.00% | – |
Q3 2017 | $49,000 | – | 23,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 169,578 | $276,000 | 0.10% |
Geneos Wealth Management Inc. | 445,200 | $725,000 | 0.05% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $20,000 | 0.01% |
Vivaldi Capital Management LP | 19,261 | $30,000 | 0.01% |
Atria Wealth Solutions, Inc. | 278,700 | $454,281 | 0.01% |
OSAIC HOLDINGS, INC. | 1,302,122 | $2,123,000 | 0.01% |
BARRETT & COMPANY, INC. | 4,984 | $5,632 | 0.00% |
Ameritas Advisory Services, LLC | 45,302 | $74,000 | 0.00% |
CENTAURUS FINANCIAL, INC. | 20,732 | $34,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 19,255 | $31,000 | 0.00% |